The potential rewards are high. But so are the risks.
News & Analysis: Arcturus Therapeutics Holdings Inc.
If coronavirus vaccine development efforts are a race, then pharmaceutical companies will need to hurdle more than clinical trials to be successful.
If you're bullish on Moderna, yes.
Blame it on Moderna. Sort of.
ARCT earnings call for the period ending March 31, 2020.